CSIMarket
 

Orthofix Medical Inc   (NASDAQ: OFIX)

Orthofix Medical Inc 's

Competitiveness




 

OFIX Sales vs. its Competitors Q1 2026



Comparing the current results to its competitors, Orthofix Medical Inc reported Revenue increase in the 1 quarter 2026 by 1.51 % year on year.
The revenue growth was below Orthofix Medical Inc 's competitors' average revenue growth of 5.48 %, achieved in the same quarter.

List of OFIX Competitors





Revenue Growth Comparisons




Net Income Comparison


Orthofix Medical Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 20.59 %

<<  OFIX Stock Performance Comparisons


Orthofix Medical Inc 's Comment on Competition and Industry Peers


The company evaluates market sizes, growth factors, technology trends, and the timing of new product introductions by itself and its competitors. Its accounting practices for in-process research and development (IPR&D) assets include discounting net cash flows, recording future development costs as expenses, and conducting impairment tests on indefinite-lived IPR&D assets.



  

Overall company Market Share Q1 2026

Overall company revenue, grew with moderate pace of 1.51 % slower than competitors within this segment.
<<  More on OFIX Market Share.
 
*Market share is calculated based on total revenue.

  News about Orthofix Medical Inc Contracts

Regulatory Scrutiny Dexcom, Orthofix, Spire Global, and Target Under InvestigationWhat Investors Need to Know

December 11, 2024
On December 11, 2024, Johnson Fistel, LLP a prominent securities law firm announced an investigation into potential securities law violations involving key executives from a selection of publicly traded companies: Dexcom, Inc. (DXCM), Orthofix Medical Inc. (NASDAQ: OFIX), Spire Global, Inc. (NYSE: SPIR), and Target Corporation (NYSE: TGT). This alert serves as a wake-up call for investors who may be holding or considering positions in these firms during a period marked by heightened regulatory scrutiny.The investigations come at a time when investors are increasingly wary of risk. Allegations of misconduct, whether corporate governance failures, misleading financial statements, or other improprieties, can le...





Publicly Traded Peers of Orthofix Medical Inc




Jin Medical International Ltd
Share Performance



-82.36%
One Year



Jin Medical International Ltd
Profile

Jin Medical International Ltd. operates in the medical technology sector in China through a variable interest entity (VIE).

More about Jin Medical International Ltd's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 361.655 mill. $ 20.687 mill. $ 1.381 mill.


Si bone inc
Share Performance



+34.18%
This Quarter



Si bone inc
Profile

SiBone Inc's business model revolves around the development and commercialization of innovative medical devices for the treatment of musculoskeletal disorders, particularly focused on the utilization of their patented iFuse Implant System.

More about Si bone inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 841.507 mill. $ 214.331 mill. $ -14.632 mill.


Vicarious Surgical Inc
Share Performance



-50.39%
30 Days



Vicarious Surgical Inc
Profile

Vicarious Surgical Inc utilizes a business model that combines robotics and virtual reality to revolutionize surgical procedures. Their technology allows surgeons to perform minimally invasive surgeries with precision and control using robotic arms guided by a virtual reality interface. By offering an innovative solution to traditional surgical methods, Vicarious Surgical aims to enhance patient outcomes while minimizing the invasiveness and risks associated with traditional procedures.

More about Vicarious Surgical Inc's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.268 mill. $ - mill. $ -42.117 mill.


Procept Biorobotics Corporation
Share Performance



-20.58%
This Quarter



Procept Biorobotics Corporation
Profile

Procept Biorobotics Corporation follows a business model focused on developing medical robotics solutions for urology procedures. Their flagship product, the AquaBeam System, utilizes waterjet technology to perform minimally invasive surgeries for patients with benign prostatic hyperplasia. The company aims to improve patient outcomes and reduce healthcare costs by providing an innovative and efficient alternative to traditional surgical methods.

More about Procept Biorobotics Corporation's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 1,181.645 mill. $ 321.012 mill. $ -102.473 mill.


Nuwellis Inc
Share Performance



-21.13%
Over The Past 5 Days



Nuwellis Inc
Profile

Nuwellis Inc.'s business model revolves around developing and commercializing innovative therapeutic solutions, predominantly focusing on fluid management to improve outcomes for patients with critical illnesses. They aim to provide advanced medical devices and solutions to healthcare professionals, addressing the pressing need for better fluid management in critical care settings.

More about Nuwellis Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.045 mill. $ 8.769 mill. $ -19.055 mill.

23 more competitors available

Sign in to see all competitors

Sources: Orthofix Medical Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Orthofix Medical Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.